These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 19760628)
21. [Effects of mitoxantrone on the activity of human protein kinase CK2 holoenzyme]. Li CM; Liu XG; Lin XC; Chen XW; Liang NC Ai Zheng; 2008 Aug; 27(8):809-15. PubMed ID: 18710613 [TBL] [Abstract][Full Text] [Related]
22. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo. Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666 [TBL] [Abstract][Full Text] [Related]
23. Validation of protein kinase CK2 as oncological target. Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877 [TBL] [Abstract][Full Text] [Related]
24. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684 [TBL] [Abstract][Full Text] [Related]
25. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
26. CK2 signaling in androgen-dependent and -independent prostate cancer. Wang G; Ahmad KA; Unger G; Slaton JW; Ahmed K J Cell Biochem; 2006 Oct; 99(2):382-91. PubMed ID: 16598768 [TBL] [Abstract][Full Text] [Related]
27. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha. Lebrin F; Chambaz EM; Bianchini L Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185 [TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802 [TBL] [Abstract][Full Text] [Related]
29. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. Li PX; Ngo D; Brade AM; Klamut HJ Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885 [TBL] [Abstract][Full Text] [Related]
30. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine. Yamane K; Kinsella TJ Clin Cancer Res; 2005 Mar; 11(6):2355-63. PubMed ID: 15788687 [TBL] [Abstract][Full Text] [Related]
31. Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro. Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Kazimierczuk Z; Grieb P; Stepien H Cell Tissue Res; 2010 May; 340(2):371-9. PubMed ID: 20383646 [TBL] [Abstract][Full Text] [Related]
32. Casein Kinase II: an attractive target for anti-cancer drug design. Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines. Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577 [TBL] [Abstract][Full Text] [Related]
34. CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma. Dixit D; Ahmad F; Ghildiyal R; Joshi SD; Sen E Exp Cell Res; 2016 May; 344(1):132-142. PubMed ID: 27001465 [TBL] [Abstract][Full Text] [Related]
35. TF--a novel cell-permeable and selective inhibitor of human protein kinase CK2 induces apoptosis in the prostate cancer cell line LNCaP. Götz C; Gratz A; Kucklaender U; Jose J Biochim Biophys Acta; 2012 Jul; 1820(7):970-7. PubMed ID: 22387500 [TBL] [Abstract][Full Text] [Related]
36. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease. Gratz A; Götz C; Jose J J Enzyme Inhib Med Chem; 2010 Apr; 25(2):234-9. PubMed ID: 19874207 [TBL] [Abstract][Full Text] [Related]
37. [Casein kinase 2, the versatile regulator of cell survival]. Volodina IuL; Shtil' AA Mol Biol (Mosk); 2012; 46(3):423-33. PubMed ID: 22888632 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and proapoptotic properties of new casein kinase II inhibitors. Koronkiewicz M; Zukowska M; Chilmonczyk Z; Orzeszko A; Kazimierczuk Z Acta Pol Pharm; 2010; 67(6):635-41. PubMed ID: 21229880 [TBL] [Abstract][Full Text] [Related]
39. DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks. Schneider CC; Hessenauer A; Götz C; Montenarh M Oncol Rep; 2009 Jun; 21(6):1593-7. PubMed ID: 19424641 [TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2. Prudent R; Moucadel V; Nguyen CH; Barette C; Schmidt F; Florent JC; Lafanechère L; Sautel CF; Duchemin-Pelletier E; Spreux E; Filhol O; Reiser JB; Cochet C Cancer Res; 2010 Dec; 70(23):9865-74. PubMed ID: 21118972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]